AN2 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 5.75 M | $6.15 M | 100.00% | 19.27% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 2.00 M | $2.14 M | -63.97% | 6.70% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 1.56 M | $1.66 M | 0.00% | 5.21% |
| VANGUARD GROUP INC | 11/13/2024 | 1.04 M | $1.11 M | 0.00% | 3.49% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 445,783 | $476,988 | 100.00% | 1.49% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 423,800 | $453,466 | 2,863.64% | 1.42% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 397,925 | $425,780 | -24.40% | 1.33% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 312,615 | $334,498 | 0.00% | 1.05% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 301,176 | $322,259 | 100.00% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 220,162 | $235,627 | 21.69% | 0.74% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 197,000 | $210,790 | 88.89% | 0.66% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 177,840 | $190,289 | 34.64% | 0.60% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 120,900 | $129,363 | -10.25% | 0.41% |
| ALDEBARAN CAPITAL, LLC | 11/13/2024 | 100,500 | $107,535 | 100.00% | 0.34% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 79,359 | $84,914 | 100.00% | 0.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 66,100 | $70,727 | 203.57% | 0.22% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 64,503 | $69,019 | 100.00% | 0.22% |
| STATE STREET CORP | 11/14/2024 | 60,302 | $64,523 | 0.00% | 0.20% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 42,335 | $45,000 | -51.31% | 0.14% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 28,667 | $30,674 | 0.00% | 0.10% |
| INTEGRATED WEALTH CONCEPTS LLC | 11/14/2024 | 25,000 | $26,750 | 100.00% | 0.08% |
| XTX TOPCO LTD | 11/14/2024 | 23,659 | $25,315 | 100.00% | 0.08% |
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 22,500 | $24,075 | 0.00% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 16,210 | $17,344 | 3.67% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,256 | $4,554 | -21.27% | 0.01% |
| MORGAN STANLEY | 11/14/2024 | 303 | $324 | -98.26% | 0.00% |
| FMR LLC | 11/13/2024 | 300 | $321 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 300 | $321 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 54 | $58 | -94.71% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RMB CAPITAL MANAGEMENT, LLC | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
AN2 Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of AN2 Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 5.75 M
RA CAPITAL MANAGEMENT, L.P.: 2 M
TCG Crossover Management, LLC: 1.56 M
VANGUARD GROUP INC: 1.04 M
Acuitas Investments, LLC: 445,783
RENAISSANCE TECHNOLOGIES LLC: 423,800
45.28% of AN2 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.75 M shares in the last 24 months. This purchase volume represents approximately $16.77 M in transactions.